Back to search

Article

Development and Clinical Validation of Global Tau Severity Score in Young- and Late- Onset Alzheimer's Disease Using Florzolotau (18F) PET

2024-02-09

Abstract excerpt

<h4>Background: </h4> Tau-specific positron emission tomography (tau-PET) holds promise in distinguishing Alzheimer's disease (AD) and elucidating the spatial distribution of tau deposition. In particular, the phenotypic differences between the young-onset AD [YOAD] and late-onset AD [LOAD] likely arise from the distinct biological properties of tau proteins to their downstream pathways. This study aimed to establ...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
00d86eb2-5b92-5817-8545-ec0a5319be60
DOI
10.21203/rs.3.rs-3932300/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Development and Clinical Validation of Global Tau Severity Score in Young- and Late- Onset Alzheimer's Disease Using Florzolotau (18F) PETDOI 10.21203/rs.3.rs-3932300/v1
Select a neighboring publication to make it the new centre.